Profitability and meat quality of fast-, medium- and slow-growing meat-type chicken genotypes as affected by growth and length of rearing.

The study aimed to evaluate the profitability, meat quality, and carcass parameters of fast-, medium-, and slow-growing meat-type chicken genotypes of Bangladesh. Nine hundred DOCs were randomly allocated to 6 treatments: T1 = commercial broilers, T2 = CPF-3 (central poultry farm-3), T3 = cockerel, T4 = sonali, T5 = NDD (non-descriptive desi), and T6 = hilly, having 5 replications of 30 chicks each. Birds were reared under complete confinement until their respective market ages (commercial broilers = 35 d; CPF-3 = 45 d; cockerel = 56 d, and hilly = 77 d; sonali = 63 d and NDD = 77 d) and fed commercial broiler diets. Net returns, meat quality, growth, and carcass yield were measured. NDD and hilly showed significantly the highest profitability and superior meat quality. Commercial broilers exhibited the highest final body weight (2355.59 g/b) followed by hilly (1241 g/b) and NDD (1006 g/b), while CPF-3 (860.21 g/b), cockerel (915.49 g/b), and sonali (788.43 g/b) had lower final body weights at their respective market ages. Commercial broilers had the highest carcass weight and dressing yields, followed by hilly and cockerel, and lower in sonali, CPF-3, and NDD. The study concluded that rearing slow- or medium-growing NDD and hilly is superior to fast-growing commercial broilers or CPF-3 regarding profitability, and meat quality. The results of current findings help small-scale farmers in choosing a suitable meat-type chicken that yields better profitability and also for the consumers who wish to pay a fair price for the birds, considering the meat quality specific to each chicken genotype.

Challenges in the profitability of small-scale broiler farming by avoiding injudicious use of drugs and additives.

The aim of the current study was to determine the present scenario of injudicious use of drugs and additives in small-scale broiler operations and whether broilers can be produced successfully and profitably without the injudicious use of drugs and additives. First, a survey was undertaken in relation to farmers' basic information and general management methods in commercial broilers, with special attention given to the usage of medications and additives in drinking water. Second, based on the survey data, an experimental trial was carried out to compare the growth performance and economic profitability of rearing broilers with and without the use of said drugs and additives. A total of 540 broiler DOCs were allotted into three treatments: T1 = self-formulated feed (SFF) with judicious use of drugs and additives; T2 = commercial feed with judicious use of drugs and additives (JUDA) and T3 = commercial feed with injudicious use of drugs and additives (InJUDA), with six replications (30 birds/replication) in each. The results showed that the farmers used a variety of drugs and additives in 35 days of broiler rearing; however, the farmers usually did not consult with veterinary practitioners, instead relying on and being instructed by local dealers and medicine company representatives. Although the medications and additives account for almost 6-8% of total production costs, the experimental trial clearly demonstrated that the broilers kept with either JUDA or InJUDA showed statistically (p < 0.05) similar BW (2181.93 g & 2222.53 g/bird), BWG (2110.0 g & 2129.91 g/bird), and FCR (1.62 & 1.57, respectively), whereas broilers in the SFF group showed significantly lower growth performances (BW = 1799.31 g/bird, BWG = 1746.19 g/bird, and FCR = 1.93, respectively). The net profit per kg bird in the JUDA group was substantially (p < 0.05) greater (BDT- 27.34/-), followed by the SFF group (BDT- 25.56/) and the InJUDA group (BDT- 24.49/-). Taken together, these findings suggest that profitable broiler farming is possible without the injudicious use of drugs and additives.